New This Month

Fri, 10/17/2014 - 14:06

Ashley Shepherd shares her story of surviving an episode of sudden cardiac arrest, receiving an ICD, and later becoming a technical service specialist with St. Jude Medical.

| Read More
Fri, 10/17/2014 - 14:01

Jason Huang, MD and Jordan M. Prutkin, MD, MHS discuss how more needs to be done to reduce sudden cardiac death in high school and college athletes in the United States.

| Read More
Fri, 10/17/2014 - 12:01

Included are highlights from the Kansas City Heart Rhythm Symposium, which took place August 16-17 at the Sheraton Kansas City at Crown Center hotel.

| Read More

NEWS

Fri, 10/17/14 - 2:12pm

CapSureFix Novus™ MRI SureScan ® 5076 Pacing Lead Approved for MR-Conditional Use in Patients with Slow Heartbeat Medtronic announced the U.S. Food and Drug Administration (FDA) approval of its CapSureFix Novus™ MRI SureScan® 5076 Lead for use with magnetic resonance imaging (MRI). The lead is approved for MRI scans positioned on any region of the body when paired with a Medtronic dual-chamber MR-conditional pacemaker.

| Full Article
Fri, 10/17/14 - 2:11pm

Genetic Causes of Atrial Fibrillation to be Explored by Experts from Around the World as Part of $6 Million Award from the Leducq Foundation

The electrophysiology service of the Massachusetts General Hospital Institute for Heart, Vascular and Stroke Care announces participation in a new Transatlantic Network of Excellence as part of a $6 million award from the Leducq Foundation. The Transatlantic Network of Excellence is made up of a team of researchers from around the world tasked with conducting first of its kind research on the genetic causes of atrial fibrillation (AF). The Institute will serve as the coordinating site in the United States (U.S.) and Amsterdam Medical Center will serve as the coordinating site for Europe. The Network will provide a platform for conducting cutting-edge and meaningful research into this common arrhythmia.

| Full Article
Fri, 10/17/14 - 1:58pm

AtriCure, Inc., a leading innovator in surgical treatments for atrial fibrillation (Afib) and left atrial appendage management (LAAM), announced enrollment in the ABLATE Post Approval Study (PAS) is complete.

As of October 3, 2014, the ABLATE PAS enrolled 365 patients at 40 hospitals across the United States. AtriCure expects to release preliminary data from the study in about a year, with a complete report expected to be published in three years.

The ABLATE PAS evaluates clinical outcomes in patients with non-paroxysmal (persistent or longstanding persistent) forms of atrial fibrillation who were treated utilizing the AtriCure Synergy Ablation System to perform the Maze IV procedure. The non-paroxysmal Afib patient group represents about half of the diagnosed patient population and who are extremely challenging to manage with conventional medical therapy or catheter ablation.

| Full Article
Fri, 10/17/14 - 1:57pm

Comprehensive Clinical Data from Randomized Trials Reviewed

| Full Article

IMAGES FROM EPLD

FROM THE CURRENT ISSUEView More

Susan Maynard, MS, RN-BC, CCNS, CCRN-CMC, Stroke Coordinator, Mount Nittany Medical Center, State College, Pennsylvania

Stroke Coordinator Susan Maynard, MS, RN-BC, CCNS, CCRN-CMC describes the process Mount Nittany Medical Center underwent to achieve Primary Stroke Center certification.

continue reading
Volume 14 - Issue 10 - October 2014   |   137 reads

Jaemin Shim, MD, Electrophysiologist, Assistant Professor, Division of Cardiology, Department of Internal Medicine, Korea University Anam Hospital Seoul, South Korea

This month we check out an EP program in Seoul, South Korea.

continue reading
Volume 14 - Issue 10 - October 2014   |   89 reads

Archana Kodali, MD1 and Koroush Khalighi, MD, FAOP, FACC, FCCP2, 1Medical Resident, Easton Hospital, Easton, Pennsylvania; 2Medical Director of the Electrophysiology Laboratory, Easton Hospital, and Clinical Professor of Medicine, Drexel University Easton, Pennsylvania

Archana Kodali, MD and Koroush Khalighi, MD, FAOP, FACC, FCCP describe the association of superior vena cava syndrome with an intracardiac device and antiphospholipid antibodies.

continue reading
Volume 14 - Issue 10 - October 2014   |   122 reads

Interview by Jodie Elrod

Texas Health Heart & Vascular Hospital Arlington, located on the campus of Texas Health Arlington Memorial Hospital, recently earned full Atrial Fibrillation Certification status from the Society of Cardiovascular Patient Care.

continue reading
Volume 14 - Issue 10 - October 2014   |   108 reads

Kenneth Yamamura, MD, FACC, Director of Electrophysiology and Bonnie McDonald, RN, EPS, RCIS, EP Lab Supervisor, Pepin Heart Institute, Florida Hospital Tampa, Tampa, Florida

Kenneth Yamamura, MD, FACC and Bonnie McDonald RN, CEPS, RCIS from the Pepin Heart Institute present a case on persistent left superior vena cava.

continue reading
Volume 14 - Issue 10 - October 2014   |   121 reads

EP LAB LIVE VIDEOS

MOST VIEWED

11/25/2013   |   25,116 views   |   0 comments
4/23/2014   |   8,880 views   |   0 comments